enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ezetimibe - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe

   Ezetimibe, sold under the brand name Zetia among others, is a medication used to treat high blood cholesterol and certain other lipid abnormalities. [3] [4] Generally it is used together with dietary changes and a statin. [5] Alone, it is less preferred than a statin. [4] It is taken by mouth. [4]

3. Ezetimibe/simvastatin - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe/simvastatin

   It is a combination of ezetimibe (known as Zetia in the United States) and the statin drug simvastatin (known as Zocor in the US). Ezetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

4. Ezetimibe/atorvastatin - Wikipedia

   en.wikipedia.org/wiki/Ezetimibe/atorvastatin

   Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug.In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [1]

5. Here’s how to pay the lowest prices for your prescription ...

   www.aol.com/finance/pay-lowest-prices...

   The generic for the cholesterol drug Zetia costs $6.80 per tablet, compared with roughly $113 at other pharmacies. ... Consider buying medications from a licensed online pharmacy in another country.

6. Dyslipidemia: What It Is & How to Treat It - AOL

   www.aol.com/dyslipidemia-treat-105700223.html

   Weight loss medications can provide added support for some people. Drugs like Wegovy and Zepbound are approved by the U.S. Food and Drug Administration (FDA) for those with overweight or obesity ...

7. The Next Cholesterol-Fighting Blockbuster Drug?

   www.aol.com/news/2013-10-18-the-next-cholesterol...

   Editor's Note: At 3:44, the speaker incorrectly stated that Zetia (ezetimibe) is an off-patent statin drug. Zetia is actually a cholesterol absorption inhibitor and its patent has not yet expired.